Clinical Trial Update: Hypogonadotropic Hypogonadism in Obese Young Males [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on hypogonadotropic hypogonadism in obese young males; study terminated with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism
• Hypogonadotropic Hypogonadism

Snippet

Sponsor: Sandeep Singh Dhindsa, M.D., F.A.C.E | Conditions: Hypogonadism, Hypogonadotropic | Phase 2 | Status: TERMINATED | Results posted: 2022-06-29